Entrada Therapeutics reported a net margin of -4,762.03% for the quarter ended Jun 2026. These financial ratios cover 19 quarters of results from Dec 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||
| EBT Margin | -12.36% | -66.49% | 41.30% | 22.08% | 42.84% | 61.03% | -81.21% | -1.94% | -84.39% | -2,201.28% | -2,693.93% | -3,007.85% | -4,534.74% | -4,758.13% | |||||
| EBIT Margin | -22.88% | -89.70% | 32.04% | 11.72% | 35.71% | 56.42% | -110.67% | -15.69% | -105.99% | -2,402.51% | -2,915.18% | -3,249.27% | -4,834.63% | -5,007.02% | |||||
| EBITDA Margin | -22.88% | -89.70% | 32.04% | 11.72% | 35.71% | 56.42% | -110.67% | -15.69% | -105.99% | -2,402.51% | -2,915.18% | -3,249.27% | -4,834.63% | -5,007.02% | |||||
| Operating Margin | -22.88% | -89.70% | 32.04% | 11.72% | 35.71% | 56.42% | -110.67% | -15.69% | -105.99% | -2,402.51% | -2,915.18% | -3,249.27% | -4,834.63% | -5,007.02% | |||||
| Net Margin | -26.62% | -142.70% | 81.09% | -22.70% | 39.74% | 58.07% | -71.50% | 2.95% | -84.39% | -2,210.41% | -2,737.30% | -3,014.93% | -4,539.09% | -4,762.03% | |||||
| FCF Margin | 771.05% | -196.86% | -61.59% | -9.13% | -44.58% | 45.11% | -147.33% | -86.21% | -192.87% | -1,526.36% | -1,743.62% | -2,463.13% | -4,770.17% | -3,616.26% | |||||
| Efficiency | |||||||||||||||||||
| Assets AverageAssets Avg. | 219.11M | 311.27M | 306.31M | 285.19M | 263.26M | 363.81M | 484.78M | 489.51M | 477.11M | 490.02M | 546.40M | 568.28M | 540.46M | 506.40M | 467.63M | 430.84M | 395.14M | 356.45M | 317.20M |
| Asset Utilization RatioAsset Util. | 0.07 | 0.09 | 0.18 | 0.27 | 0.33 | 0.44 | 0.38 | 0.39 | 0.34 | 0.17 | 0.14 | 0.06 | 0.02 | 0.01 | |||||
| Valuation | |||||||||||||||||||
| Price to EarningsP/E | -5.82 | -13.55 | -16.44 | -19.64 | -17.23 | -71.46 | -19.39 | 14.85 | -53.11 | 20.27 | 9.63 | -42.71 | 587.93 | -19.77 | -5.93 | -5.02 | -10.05 | -12.34 | -6.70 |
| Price to SalesP/S | 19.02 | 27.67 | 12.04 | 12.06 | 8.05 | 5.59 | 30.54 | 17.37 | 16.68 | 131.07 | 137.34 | 302.97 | 559.90 | 319.12 | |||||
| Price to BookP/B | 0.36 | 1.06 | 1.49 | 2.12 | 2.00 | 2.09 | 2.43 | 2.14 | 2.08 | 1.77 | 1.23 | 1.41 | 1.52 | 0.82 | 0.67 | 0.65 | 1.29 | 1.81 | 1.23 |
| Enterprise Value | -183.76M | 29.67M | 136.79M | 278.12M | 379.30M | 252.79M | 422.99M | 474.89M | 436.97M | 407.73M | 344.46M | 519.61M | 548.45M | 275.16M | 183.11M | 128.39M | 302.51M | 413.47M | 187.29M |
| EV to EBIT | 9.95 | -1.34 | -5.80 | -10.72 | -14.83 | -43.74 | -25.95 | 33.89 | 89.09 | 19.31 | 6.45 | -23.99 | -93.48 | -12.63 | -3.91 | -2.73 | -7.17 | -9.77 | -4.17 |
| EV to EBITDA | 9.95 | -1.34 | -5.80 | -10.72 | -14.83 | -43.74 | -25.95 | 33.89 | 89.09 | 19.31 | 6.45 | -23.99 | -93.48 | -12.63 | -3.91 | -2.73 | -7.17 | -9.77 | -4.17 |
| Market Capitalization | 107.30M | 293.57M | 381.04M | 493.69M | 424.46M | 480.44M | 502.73M | 526.78M | 504.57M | 476.17M | 529.71M | 597.66M | 649.66M | 343.00M | 255.59M | 221.67M | 393.56M | 489.92M | 286.57M |
| Price to FCFP/FCF | -4.91 | -13.60 | -20.29 | -17.45 | -14.41 | 2.47 | -14.06 | -19.56 | -132.02 | -18.07 | 12.40 | -20.73 | -20.15 | -8.65 | -8.59 | -7.88 | -12.30 | -11.74 | -8.82 |
| EV to FCF | 8.41 | -1.37 | -7.28 | -9.83 | -12.87 | 1.30 | -11.83 | -17.63 | -114.33 | -15.47 | 8.06 | -18.02 | -17.01 | -6.94 | -6.15 | -4.56 | -9.45 | -9.91 | -5.77 |
| EV to CFO | 8.95 | -1.41 | -7.60 | -10.12 | -13.89 | 1.24 | -12.05 | -19.39 | -108.89 | -15.98 | 8.65 | -21.41 | -17.35 | -7.15 | -6.21 | -4.53 | -9.39 | -9.92 | -5.77 |
| Return Ratios | |||||||||||||||||||
| Return on Sales [ROS]ROS | -22.88% | -89.70% | 32.04% | 11.72% | 35.71% | 56.42% | -110.67% | -15.69% | -105.99% | -2,402.51% | -2,915.18% | -3,249.27% | -4,834.63% | -5,007.02% | |||||
| Return on Capital Employed [ROCE]ROCE | -24.07% | -21.93% | -27.25% | -34.19% | -40.30% | -37.41% | -20.51% | -10.38% | -0.99% | 7.51% | 20.29% | 11.61% | 9.38% | 0.84% | -21.47% | -29.88% | -42.60% | -52.90% | -59.67% |
| Return on Assets [ROA]ROA | -23.35% | -20.71% | -25.38% | -31.01% | -35.94% | -21.90% | -17.00% | -4.46% | -1.40% | 4.80% | 19.12% | 9.68% | 12.14% | 4.89% | -15.68% | -24.03% | -36.39% | -46.62% | -52.28% |